L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial.
about
Recoupling the cardiac nitric oxide synthases: tetrahydrobiopterin synthesis and recyclingNew insights into male (in)fertility: the importance of NOL-citrulline provides a novel strategy for treating chronic pulmonary hypertension in newborn infantsArginase induction and activation during ischemia and reperfusion and functional consequences for the heartDrug discovery for Duchenne muscular dystrophy via utrophin promoter activation screeningL-Arginine supplementation or arginase inhibition augments reflex cutaneous vasodilatation in aged human skin.Effects of exercise and L-arginine on ventricular remodeling and oxidative stress.Pharmacotherapy for end-stage coronary artery disease.Vascular dysfunction in retinopathy-an emerging role for arginaseThe biomarker and causal roles of homoarginine in the development of cardiometabolic diseases: an observational and Mendelian randomization analysis.The effect of L-arginine and creatine on vascular function and homocysteine metabolism.Therapeutic angiogenesis in diabetes and hypercholesterolemia: influence of oxidative stress.Long term exposure to L-arginine accelerates endothelial cell senescence through arginase-II and S6K1 signalingSex-specific factors in microvascular angina.The prognostic biomarker L-homoarginine is a substrate of the cationic amino acid transporters CAT1, CAT2A and CAT2B.L-arginine as a nutritional prophylaxis against vascular endothelial dysfunction with aging.Effect of hawthorn standardized extract on flow mediated dilation in prehypertensive and mildly hypertensive adults: a randomized, controlled cross-over trialL-arginine reactivity in cerebral vessels after severe traumatic brain injury.Essential Nutrients for Bone Health and a Review of their Availability in the Average North American Diet.Insulin reduces plasma arginase activity in type 2 diabetic patients.Asymmetric dimethylarginine correlates with measures of disease severity, major adverse cardiovascular events and all-cause mortality in patients with peripheral arterial disease.Reference intervals for plasma L-arginine and the L-arginine:asymmetric dimethylarginine ratio in the Framingham Offspring CohortEffects of Oral L-Citrulline Supplementation on Lipoprotein Oxidation and Endothelial Dysfunction in Humans with Vasospastic AnginaNitric Oxide Bioavailability in Obstructive Sleep Apnea: Interplay of Asymmetric Dimethylarginine and Free Radicals.Continuous exposure to L-arginine induces oxidative stress and physiological tolerance in cultured human endothelial cells.Up Regulation of cystathione γ lyase and Hydrogen Sulphide in the Myocardium Inhibits the Progression of Isoproterenol-Caffeine Induced Left Ventricular Hypertrophy in Wistar Kyoto RatsRescue Treatment with L-Citrulline Inhibits Hypoxia-Induced Pulmonary Hypertension in Newborn Pigs.Nitric oxide and geriatrics: Implications in diagnostics and treatment of the elderly.Asymmetric and Symmetric Dimethylarginine as Risk Markers for Total Mortality and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Prospective StudiesPharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolismModular protein supplements and their application to long-term care.Therapeutic use of citrulline in cardiovascular disease.Dietary intervention in the management of prostate cancer.Arginase: the emerging therapeutic target for vascular oxidative stress and inflammation.AMP-activated protein kinase regulates L-arginine mediated cellular responses.Selective up-regulation of arginase-1 in coronary arteries of diabetic patients.An increased need for dietary cysteine in support of glutathione synthesis may underlie the increased risk for mortality associated with low protein intake in the elderlyArginine, nitric oxide, carbon monoxide, and endothelial function in severe malaria.L-arginine supplementation reduces cardiac noradrenergic neurotransmission in spontaneously hypertensive rats.Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk
P2860
Q26822833-C1735AF0-C6A8-46BB-B212-FA38A1D67619Q26827970-BE8D1A41-ACBE-4B1B-A26B-3264F5B9DEF3Q26829856-0D26B278-07CE-4AA3-8D66-C93FB0C8ECCBQ28081566-627A10E6-1779-4D13-842B-456170A475A7Q28477551-AECF9881-993F-4A9F-89E1-0DCE17C598C1Q33242325-C82126CC-E8FD-4D7F-A54D-76E6A23F04C4Q33601698-EAE2856B-B63C-4585-93CA-3DD7A69EC65DQ33610142-F85C60C9-494E-41FF-A3BC-3D9F9091CC0EQ33625727-E50DA798-9A47-4C0E-9F95-5C72A8389FD9Q33681854-03B62612-59EB-4945-8A96-936968B122F1Q33734265-B0458A84-BFFA-409A-AA3F-D4C203D0C368Q33765479-4CC9AB52-2786-42D5-B93E-2FA7E2AFDA13Q33801191-926CB02E-E21E-49FB-808F-31E36D51CA44Q33818831-28496591-64E3-46B8-87E6-B11A5A774479Q33881223-74581CCA-6F06-4CC4-810F-9F6E701E85BEQ34070390-54D5F01D-BF53-4F9F-944A-802C327A52D0Q34212705-AEABA199-600D-4E21-8870-66A697DFC616Q34217575-7D55FE34-672E-4C0A-8B7A-665AE2C0CE8CQ34270082-12AAB9D8-5366-4DF3-92CF-BA8E44C4D2B4Q35005301-23DAE9CC-0161-4CA3-8E3C-725453CF358BQ35090446-EB11B358-F564-40E5-809C-8BDADF1F2CDCQ35572566-CF7EA588-6590-4F84-9D71-FF4B815CB28FQ35618773-85347DCF-6F8A-4858-9D34-5DC177ABEE32Q35625951-291E7F4E-F7ED-429E-9CB4-A833A9519D45Q35874747-F28CA31C-24A3-4580-AED6-21DF4407CC2AQ35952559-4078AF1A-4130-4C22-AB85-5D363AAF5F4EQ36049218-AEFD5E10-7BB5-42CC-8A5D-F42D3AFEE43CQ36077331-1388673E-D48B-4D1F-89EC-90E16B5A421DQ36182184-86E73ACD-DA49-47B4-94AA-199BD9075AB4Q36536026-F794C708-2696-4588-AC68-842807CA26ACQ36602399-A3AE0D66-180D-49C4-939A-C09B8098134EQ36703841-61CAECD8-0B7F-46B9-AA96-D1DC2CCE00BEQ36783669-2CA88906-2B24-4FAB-B6F0-F5D19736D11CQ36920831-753C6D65-C6E4-4C0C-9BDA-532B6990992CQ36923029-B27E3F7B-1620-45C7-A17A-8FF0665D7697Q37199274-6D778BB6-8944-415C-A3D0-329DC55D85DAQ37219282-990F5101-FC72-41A6-B0EB-982B04D75F7AQ37251599-EAB46B99-99F8-4942-A410-12B526D2E4B6Q37324756-318A411C-323A-4F8A-9C58-82F97832A31BQ37370572-7262A44B-095D-4679-AADE-744F838AAECE
P2860
L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
L-arginine therapy in acute my ...... MI) randomized clinical trial.
@en
L-arginine therapy in acute my ...... h Age in Myocardial Infarction
@nl
type
label
L-arginine therapy in acute my ...... MI) randomized clinical trial.
@en
L-arginine therapy in acute my ...... h Age in Myocardial Infarction
@nl
prefLabel
L-arginine therapy in acute my ...... MI) randomized clinical trial.
@en
L-arginine therapy in acute my ...... h Age in Myocardial Infarction
@nl
P2093
P356
P1476
L-arginine therapy in acute my ...... MI) randomized clinical trial.
@en
P2093
Anne Capriotti
David A Kass
Gary Gerstenblith
Hunter C Champion
Joshua M Hare
Kavita V Ernst
Lewis C Becker
Mark D Kelemen
Michael L Terrin
Sandra Forman
P356
10.1001/JAMA.295.1.58
P407
P577
2006-01-01T00:00:00Z